Clinical Trials Logo

Serotonin Syndrome clinical trials

View clinical trials related to Serotonin Syndrome.

Filter by:

NCT ID: NCT00412061 Completed - Carcinoid Tumor Clinical Trials

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

RADIANT-2
Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate whether everolimus 10 mg / day added to treatment with depot octreotide prolongs progression free survival compared to treatment with octreotide alone in patients with advanced carcinoid tumor.

NCT ID: NCT00092287 Terminated - Clinical trials for Malignant Carcinoid Syndrome

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The aim of this study is to compare the efficacy and safety of lanreotide Autogel and Sandostatin LAR Depot, to see whether these two 28-day prolonged release formulations produce a similar clinical response in patients with carcinoid syndrome.